Histone Deacetylase Inhibition Has Targeted Clinical Benefit in <i>ARID1A</i> -Mutated Advanced Urothelial Carcinoma
Sumati Gupta(University of Utah), Sunil Sharma(University of Utah), Bradley R. Cairns(Howard Hughes Medical Institute), Joshua D. Schiffman(University of Utah), Brian K. Dalley(University of Utah), Lisa M. Pappas(University of Utah), Andrew Butterfield(University of Utah), Daniel J. Albertson(University of Utah), Alexis Weston(Translational Genomics Research Institute), William T. Lowrance(University of Utah), Timothy J. Parnell(University of Utah)
Cited by 24
Related Papers
The adult human testis transcriptional cell atlas
|Cell Research|2018|769
Comparative oncology: what dogs and other species can teach us about humans with cancer
|Philosophical Transactions of the Royal Society B Biological Sciences|2015|440
Monogenic and polygenic determinants of sarcoma risk: an international genetic study
|The Lancet Oncology|2016|213